Pneumoconiosis Market Analysis by Major Key Players and Types
Pneumoconiosis occurs when a person inhales particle such as asbestos, coal dust, or silica. Some time it may causes inflammation in the lungs. A number of different factors are responsible for causing pneumoconiosis. Global pneumoconiosis market is majorly driven by the increasing prevalence of pneumoconiosis.
Smoking increases the possibility of the pneumoconiosis,
thereby, the rapidly increasing number of smokers has also contributed in the
growth of the market. On the other hand, lack of absolute treatment may
restrain the market growth.
According to the Centers for Disease Control and
Prevention, in 2013, pneumoconiosis was responsible for 260,000 deaths across
the globe. Moreover, increasing pollution, changing lifestyle and increasing
geriatric population have fueled the growth of the market.
The global pneumoconiosis market is expected to grow
at a CAGR of 6.8% during forecast period.
Avail a FREE Sample Copy at https://www.marketresearchfuture.com/sample_request/4639
Key Players:
The key players for the global pneumoconiosis market are –
- Abbott (US) Eli Lilly (US)
- Sunpharma (India)
- Sanofi (France)
- Novo Nordisk (Denmark)
- Novartis (Switzerland)
- Abbott (US)
- AstraZeneca (UK)
- Merck & Co. (U.S.)
- Pfizer (U.S.)
- Svizera Healthcare (India)
- Hoffman La Roche AG (Germany)
- Bayer Cropscience Ltd. (U.S.)
Segmentation:
The global pneumoconiosis market is segmented on the basis
of types, causes, therapy, and end users.
On the basis of type, the market is segmented into asbestosis, berylliosis, byssinosis,
coal workers pneumoconiosis, silicosis, and others.
On the basis of cause, the market is categorized into organic dusts, non-organic
substances, and others. Organic substances are further segmented into hay,
malt, mushrooms, and others. Non organic substances are further segmented into
sulphur dioxide, ammonia, nitrogen dioxide, and others.
On the basis of therapy, the market is segmented into diagnosis, and treatment. Diagnosis
is further segmented into chest X-ray, CT scan, and others. Treatment is
further classified into mucolytic agent, antibiotic, and others.
On the basis of end user, the market is segmented into hospital, clinics, and others.
Intended Audience
- Biotechnological institutes
- Pharmaceutical companies
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/pneumoconiosis-market-4639
Regional Analysis
The Americas dominate the global pneumoconiosis market
owing to a large patient population, strong government support for research
& development, and high healthcare spending. Smoking increase the risk of
causing this disease. According to the Centers for Disease Control and
Prevention, in 2015, about 15 in every 100 U.S. adults aged over 18 years smoked
cigarettes. Which is estimated around 36.5 million adults in the United States
currently smoke cigarettes. Moreover, changing lifestyle and increasing number
of smokers has fuelled the growth of the market.
Europe has the second leading market in global
pneumoconiosis market which is followed by Asia Pacific. Asia Pacific is the
fastest growing market for pneumoconiosis. As per statistics, more than half of
the china population smoke. China and India contribute a major share in the
Asia Pacific pneumoconiosis market. Increasing geriatric population and
increasing air pollution in this region have fuelled the growth of the market.
The Middle East and Africa contribute the least in the
growth of global pneumoconiosis market. The UAE, Saudi Arabia, and Kuwait are
expected to drive the Middle East & African market. Africa holds the least
share of the global market due to limited availability of medical facilities
and poor economic condition. However the growth of the Africa market is high
due to the presence of opportunities for the development of the market.
About Market Research Future: Our market research studies by products, services, technologies,
applications, end users, and market players for global, regional, and country
level market segments, enable our clients to see more, know more, and do more,
which help to answer all their most important questions.
In order to stay updated with technology and work process
of the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment